#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cold type haemolytic anaemia Synovial sarcoma metastatic Blood iron increased Arteriosclerosis Acute lymphocytic leukaemia recurrent Endometrial adenocarcinoma Choroid melanoma Antiphospholipid antibodies Round cell liposarcoma Congenital hypotransferrinaemia Erdheim-Chester disease Erythema Leukaemia Superficial vein thrombosis Osteosarcoma metastatic More trials…

    Learn about Rare Diseases

    Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Basic Information Synovial sarcoma metastatic – Life with Disease CADASIL – Life with Disease Toxic epidermal necrolysis – Treatment Wiskott-Aldrich syndrome – Treatment Ocular melanoma – Treatment Acquired haemophilia Ornithine transcarbamoylase deficiency – Life with Disease Anaplastic thyroid cancer – Diagnostics Advanced systemic mastocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    A52 Idarubicin Rosuvastatin Calcium ZILUCOPLAN MARALIXIBAT Incb000928 Lu Ag09222 Hydroxypropyl Cellulose Lf Olaptesed Pegol Doxecitine HALOBETASOL PROPIONATE Timrepigene Emparvovec Amiloride Xaluritamig Tenofovir Disoproxil Encorafenib Ab-729 Exagamglogene Autotemcel Setanaxib Vosilasarm More therapies…

    Learn about Your Condition

    Hereditary optic atrophy Ocular myasthenia Plasma cell myeloma recurrent Pneumococcal infection Lung adenocarcinoma stage IV Colour blindness Thyroidectomy Systemic lupus erythematosus Arthroscopy Menopausal symptoms Fallopian tube cancer Staphylococcal bacteraemia Pituitary tumour benign Cutaneous calcification Mesothelioma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Endocrine ophthalmopathy

  • AMG 732 in Patients With Thyroid Eye Disease Who Did Not Respond or Relapsed After Previous Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • AMG 732
    France Greece Italy Poland Spain

  • Study of K1-70 compared to placebo for patients with active thyroid eye disease from Graves’ disease

    Recruiting

    2 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • HUMAN IGG1 MONOCLONAL ANTIBODY AGAINST THYROTROPIN RECEPTOR
    Italy Spain

  • Study on Treating Graves’ Eye Disease with Diclofenac or Simvastatin for Patients with Mild to Moderate Symptoms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Diclofenac Diethylamine
    • Simvastatin
    Sweden

  • Study Comparing Sirolimus and Methylprednisolone for Patients with Active Thyroid Eye Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Sirolimus
    • Methylprednisolone
    Norway

  • A study testing teprotumumab compared to placebo in adult patients with moderate-to-severe active thyroid eye disease

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Teprotumumab
    France Germany Italy Poland Spain

  • A study to test if atorvastatin can prevent eye disease in patients newly diagnosed with Graves’ disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    • Graves’ disease
    Investigated Drugs:
    • Atorvastatin
    Sweden
1 2 3 … 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!